Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Naushad Shaik

Clinical Cardiac Electrophysiology Kissimmee, FL Medical Doctor

NPI 1447436126 CMS profile 155977

601 Oak Commons Blvd, Kissimmee, FL 34741

Open in the dashboard

General payments

$690,722

1,175 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$409,136 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Naushad Shaik of Kissimmee, FL is reported in the CMS Open Payments database as having received $690,722 across 1,175 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $409,136 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $145,956 232
2024 General $103,558 188
2023 General $81,615 139
2022 General $75,691 147
2021 General $90,341 121
2020 General $87,547 117
2019 General $106,013 231

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Naushad Shaik
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Naushad Shaik were reported at $145,956. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Naushad Shaik Clinical Cardiac Electrophysiology median Middle half National median
2019 $106,013 $2,361 $585–$8,260 $163
2020 $87,547 $993 $247–$4,351 $114
2021 $90,341 $1,185 $326–$4,739 $132
2022 $75,691 $2,073 $554–$6,789 $149
2023 $81,615 $2,568 $759–$8,159 $160
2024 $103,558 $2,557 $703–$7,403 $164
2025 $145,956 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $350,003 498 payments
  2. Biotronik Inc. $119,905 225 payments
  3. Acutus Medical, Inc. $80,556 51 payments
  4. Medical Device Business Services, Inc. $61,450 46 payments
  5. Abbott Laboratories $31,306 75 payments
  6. Medtronic, Inc. $12,476 83 payments
  7. Biosense Webster, Inc. $11,360 67 payments
  8. Galvanize Therapeutics, Inc $5,638 2 payments
  9. Cardiva Medical, Inc. $5,050 12 payments
  10. Atricure, Inc. $2,846 20 payments
  11. Other $10,133 96 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $265,979 153 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $262,824 280 payments
  3. Travel and Lodging $73,028 125 payments
  4. Food and Beverage $40,055 587 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $28,025 17 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $12,850 7 payments
  7. Honoraria $5,875 3 payments
  8. Grant $2,000 1 payment
  9. Education $85 2 payments
Products named General payments · program years 2019–2025
  1. General - EP $62,109 66 payments
  2. Carto 3 $61,073 95 payments
  3. EMBLEM MRI S-ICD $20,500 15 payments
  4. General - Therapies $16,723 18 payments
  5. Acticor 7 VR-T DX $16,279 21 payments
  6. Acticor $15,155 39 payments
  7. WATCHMAN Access System $14,869 15 payments
  8. SQ RX PULSE GENERATOR $14,471 9 payments
  9. S-ICD System Magnet $14,221 6 payments
  10. Edora $13,955 38 payments
  11. Other $260,857 663 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 37 drugs

Part D claims

2,541

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$715,094

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

30.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 357 $405,067
Xarelto Rivaroxaban Brand 108 $120,030
Entresto Sacubitril/Valsartan Brand 70 $92,918
Jardiance Empagliflozin Brand 32 $37,294
Farxiga Dapagliflozin Propanediol Brand 11 $18,635
Amiodarone Hcl Generic 149 $7,031
Metoprolol Succinate Generic 340 $5,545
Dofetilide Generic 18 $4,915
Diltiazem 12hr Er Diltiazem Hcl Brand 14 $3,304
Flecainide Acetate Generic 86 $2,797

The 10 drugs with the highest cost, of 37 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$608,580

Medicare's payments for the services billed

Medicare patients

1,033

Average age 77

Services billed

7,213

477 women, 556 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Atrial fibrillation 56%
Arthritis 51%
Diabetes 45%
Chronic kidney disease 44%
Heart failure 43%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Sotalol Hydrochloride
$600 39 —
Arcalyst
$123 — —
ONPATTRO
$28 — —
XARELTO
$19 108 —
FARXIGA
$15 11 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,175 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record